These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28904188)

  • 21. Norovirus GII.4 antibodies in the Portuguese population.
    Mesquita JR; Nascimento MS
    J Infect Dev Ctries; 2014 Sep; 8(9):1201-4. PubMed ID: 25212086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological Correlates of Protection against a GII.4 Norovirus.
    Atmar RL; Bernstein DI; Lyon GM; Treanor JJ; Al-Ibrahim MS; Graham DY; Vinjé J; Jiang X; Gregoricus N; Frenck RW; Moe CL; Chen WH; Ferreira J; Barrett J; Opekun AR; Estes MK; Borkowski A; Baehner F; Goodwin R; Edmonds A; Mendelman PM
    Clin Vaccine Immunol; 2015 Aug; 22(8):923-9. PubMed ID: 26041041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal Antigenic Evolution after a Decade of Norovirus GII.4 Sydney_2012 Circulation in Humans.
    Parra GI; Tohma K; Ford-Siltz LA; Eguino P; Kendra JA; Pilewski KA; Gao Y
    J Virol; 2023 Feb; 97(2):e0171622. PubMed ID: 36688654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of GII.P16-GII.2 Recombinant Norovirus Strain with Increased Norovirus Outbreaks, Guangdong, China, 2016.
    Lu J; Fang L; Sun L; Zeng H; Li Y; Zheng H; Wu S; Yang F; Song T; Lin J; Ke C; Zhang Y; Vinjé J; Li H
    Emerg Infect Dis; 2017 Jul; 23(7):1188-1190. PubMed ID: 28430561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of a novel GII.17 norovirus – End of the GII.4 era?
    de Graaf M; van Beek J; Vennema H; Podkolzin AT; Hewitt J; Bucardo F; Templeton K; Mans J; Nordgren J; Reuter G; Lynch M; Rasmussen LD; Iritani N; Chan MC; Martella V; Ambert-Balay K; Vinjé J; White PA; Koopmans MP
    Euro Surveill; 2015 Jul; 20(26):. PubMed ID: 26159308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of GII.4 norovirus persistence in human populations.
    Lindesmith LC; Donaldson EF; Lobue AD; Cannon JL; Zheng DP; Vinje J; Baric RS
    PLoS Med; 2008 Feb; 5(2):e31. PubMed ID: 18271619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological Cross-Reactivity of an Ancestral and the Most Recent Pandemic Norovirus GII.4 Variant.
    Tamminen K; Malm M; Vesikari T; Blazevic V
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30678195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.
    Debbink K; Lindesmith LC; Donaldson EF; Costantini V; Beltramello M; Corti D; Swanstrom J; Lanzavecchia A; Vinjé J; Baric RS
    J Infect Dis; 2013 Dec; 208(11):1877-87. PubMed ID: 23908476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norovirus outbreaks in Beijing, China, from 2014 to 2017.
    Gao Z; Liu B; Yan H; Li W; Jia L; Tian Y; Chen Y; Wang Q; Pang X
    J Infect; 2019 Aug; 79(2):159-166. PubMed ID: 31150745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype.
    Tamminen K; Huhti L; Vesikari T; Blazevic V
    Viral Immunol; 2013 Apr; 26(2):167-70. PubMed ID: 23438469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of norovirus genogroup I, II and IV seroprevalence among children in the Netherlands, 1963, 1983 and 2006.
    van Beek J; de Graaf M; Xia M; Jiang X; Vinjé J; Beersma M; de Bruin E; van de Vijver D; Holwerda M; van Houten M; Buisman AM; van Binnendijk R; Osterhaus ADME; van der Klis F; Vennema H; Koopmans MPG
    J Gen Virol; 2016 Sep; 97(9):2255-2264. PubMed ID: 27365054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of norovirus GII-4 antibodies in Finnish children.
    Nurminen K; Blazevic V; Huhti L; Räsänen S; Koho T; Hytönen VP; Vesikari T
    J Med Virol; 2011 Mar; 83(3):525-31. PubMed ID: 21264875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete nucleotide sequence analysis of the norovirus GII.17: A newly emerging and dominant variant in China, 2015.
    Wang HB; Wang Q; Zhao JH; Tu CN; Mo QH; Lin JC; Yang Z
    Infect Genet Evol; 2016 Mar; 38():47-53. PubMed ID: 26687061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Norovirus genotype diversity associated with gastroenteritis outbreaks in Victoria in 2013.
    Bruggink LD; Dunbar NL; Catton MG; Marshall JA
    Commun Dis Intell Q Rep; 2015 Mar; 39(1):E34-41. PubMed ID: 26063096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses.
    Alvarado G; Salmen W; Ettayebi K; Hu L; Sankaran B; Estes MK; Venkataram Prasad BV; Crowe JE
    Nat Commun; 2021 Jul; 12(1):4320. PubMed ID: 34262046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Within-host evolution results in antigenically distinct GII.4 noroviruses.
    Debbink K; Lindesmith LC; Ferris MT; Swanstrom J; Beltramello M; Corti D; Lanzavecchia A; Baric RS
    J Virol; 2014 Jul; 88(13):7244-55. PubMed ID: 24648459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
    Lindesmith LC; Ferris MT; Mullan CW; Ferreira J; Debbink K; Swanstrom J; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS
    PLoS Med; 2015 Mar; 12(3):e1001807. PubMed ID: 25803642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered patterns of norovirus GII.b recombinant forms in gastroenteritis outbreaks in Victoria, Australia, 2002-2005 compared to 2006-2011.
    Bruggink LD; Marshall JA
    J Med Virol; 2013 Aug; 85(8):1433-43. PubMed ID: 23765780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.
    Debbink K; Donaldson EF; Lindesmith LC; Baric RS
    J Virol; 2012 Jan; 86(2):1214-26. PubMed ID: 22090110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic analyses of norovirus GII.4 variants in Finnish children from 1998 to 2013.
    Huhti L; Blazevic V; Puustinen L; Hemming M; Salminen M; Vesikari T
    Infect Genet Evol; 2014 Aug; 26():65-71. PubMed ID: 24837668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.